The DOI matches its Crossref record; 123 of the 123 references it cites were found in a registry or an index.
Unusual Amino Acids in Medicinal Chemistry
Abstract
Unusual amino acids are fundamental building blocks of modern medicinal chemistry. The combination of readily functionalized amine and carboxyl groups attached to a chiral central core along with one or two potentially diverse side chains provides a unique three-dimensional structure with a high degree of functionality. This makes them invaluable as starting materials for syntheses of complex molecules, highly diverse elements for SAR campaigns, integral components of peptidomimetic drugs, and potential drugs on their own. This Perspective highlights the diversity of unnatural amino acid structures found in hit-to-lead and lead optimization campaigns and clinical stage and approved drugs, reflecting their increasingly important role in medicinal chemistry.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success
Lovering, F., Bikker, J., & Humblet, C. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm901241e · Cited by 4,495
Peptide therapeutics: current status and future directions
Fosgerau, K., & Hoffmann, T. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2014.10.003 · Cited by 3,030
The Medicinal Chemist’s Toolbox: An Analysis of Reactions Used in the Pursuit of Drug Candidates
Roughley, S. D., & Jordan, A. M. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200187y · Cited by 2,725
The Future of Peptide‐based Drugs
Craik, D. J., Fairlie, D. P., Liras, S., & Price, D. (2013) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12055 · Cited by 1,979
Escape from Flatland 2: complexity and promiscuity
Lovering, F. (2013) · MedChemComm · doi:10.1039/c2md20347b · Cited by 1,444
Knowles, W. S. (2002) · Angewandte Chemie International Edition · Cited by 1,341
Patil, S. T., Zhang, L., Martenyi, F., Lowe, S. L., Jackson, K. A., Andreev, B. V., Avedisova, A. S., Bardenstein, L. M., Gurovich, I. Y., Morozova, M. A., et al. (2007) · Nature Medicine · doi:10.1038/nm1632 · Cited by 1,040
Schafmeister, C. E., Po, J., & Verdine, G. L. (2000) · Journal of the American Chemical Society · doi:10.1021/ja000563a · Cited by 1,037
Asymmetric Hydrogenations (Nobel Lecture 2001)
Knowles, W. S. (2003) · Advanced Synthesis & Catalysis · doi:10.1002/adsc.200390028 · Cited by 940
Rational Design of Peptide-Based HIV Proteinase Inhibitors
Roberts, N. A., Martin, J. A., Kinchington, D., Broadhurst, A. V., Craig, J. C., Duncan, I. B., Galpin, S. A., Handa, B. K., Kay, J., Kröhn, A., et al. (1990) · Science · doi:10.1126/science.2183354 · Cited by 929
An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus
Lamarre, D., Anderson, P. C., Bailey, M., Beaulieu, P., Bolger, G., Bonneau, P., Bös, M., Cameron, D. R., Cartier, M., Cordingley, M. G., et al. (2003) · Nature · doi:10.1038/nature02099 · Cited by 917
Crystal structure of the human angiotensin-converting enzyme–lisinopril complex
Natesh, R., Schwager, S. L. U., Sturrock, E. D., & Acharya, K. R. (2003) · Nature · doi:10.1038/nature01370 · Cited by 888
An Expanded Eukaryotic Genetic Code
Chin, J. W., Cropp, T. A., Anderson, J. C., Mukherji, M., Zhang, Z., & Schultz, P. G. (2003) · Science · doi:10.1126/science.1084772 · Cited by 820
Diverse taxa of cyanobacteria produce β- N -methylamino- l -alanine, a neurotoxic amino acid
Cox, P. A., Banack, S. A., Murch, S. J., Rasmussen, U., Tien, G., Bidigare, R. R., Metcalf, J. S., Morrison, L. F., Codd, G. A., & Bergman, B. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501526102 · Cited by 707
Agonists and antagonists for excitatory amino acid receptors
Watkins, J. C., & Olverman, H. J. (1987) · Trends in Neurosciences · doi:10.1016/0166-2236(87)90171-8 · Cited by 693
Selenocysteine: the 21st amino acid
Böck, A., Forchhammer, K., Heider, J., Leinfelder, W., Sawers, G., Veprek, B., & Zinoni, F. (1991) · Molecular Microbiology · doi:10.1111/j.1365-2958.1991.tb00722.x · Cited by 686
Dopamine visualized in the basal ganglia of living man
Garnett, E. S., Firnau, G., & Nahmias, C. (1983) · Nature · doi:10.1038/305137a0 · Cited by 644
Augeri, D. J., Robl, J. A., Betebenner, D. A., Magnin, D. R., Khanna, A., Robertson, J. G., Wang, A., Simpkins, L. M., Taunk, P., Huang, Q., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050261p · Cited by 624
Site-selective protein-modification chemistry for basic biology and drug development
Krall, N., da Cruz, F. P., Boutureira, O., & Bernardes, G. J. L. (2016) · Nature Chemistry · doi:10.1038/nchem.2393 · Cited by 583
L-735,524: an orally bioavailable human immunodeficiency virus type 1 protease inhibitor.
Vacca, J. P., Dorsey, B. D., Schleif, W. A., Levin, R. B., McDaniel, S. L., Darke, P. L., Zugay, J., Quintero, J. C., Blahy, O. M., & Roth, E. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.4096 · Cited by 527
Pharmacology of Polymyxins: New Insights into an ‘Old‘ Class of Antibiotics
Velkov, T., Roberts, K. D., Nation, R. L., Thompson, P. E., & Li, J. (2013) · Future Microbiology · doi:10.2217/fmb.13.39 · Cited by 452
Suicide substrates: mechanism-based enzyme inactivators
Walsh, C. (1982) · Tetrahedron · doi:10.1016/0040-4020(82)85068-0 · Cited by 447
A New UAG-Encoded Residue in the Structure of a Methanogen Methyltransferase
Hao, B., Gong, W., Ferguson, T. K., James, C. M., Krzycki, J. A., & Chan, M. K. (2002) · Science · doi:10.1126/science.1069556 · Cited by 420
Constraining Cyclic Peptides To Mimic Protein Structure Motifs
Hill, T. A., Shepherd, N. E., Diness, F., & Fairlie, D. P. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201401058 · Cited by 418
The neurochemistry of Parkinson's disease: effect of L-dopa therapy.
Lloyd, K. G., Davidson, L., & Hornykiewicz, O. (1975) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)30363-0 · Cited by 396
Echinocandin Antifungal Drugs in Fungal Infections: A Comparison
Chen, S. C.-A., Slavin, M. A., & Sorrell, T. C. (2011) · Drugs · doi:10.2165/11585270-000000000-00000 · Cited by 371
Zimmerman, E. S., Heibeck, T. H., Gill, A., Li, X., Murray, C. J., Madlansacay, M. R., Tran, C., Uter, N. T., Yin, G., Rivers, P. J., et al. (2014) · Bioconjugate Chemistry · doi:10.1021/bc400490z · Cited by 363
Addition of the keto functional group to the genetic code of Escherichia coli
Wang, L., Zhang, Z., Brock, A., & Schultz, P. G. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0234824100 · Cited by 356
Levothyroxine Therapy in Patients with Thyroid Disease
Mandel, S. J., Brent, G. A., & Larsen, P. R. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-6-199309150-00009 · Cited by 324
A general approach to site-specific antibody drug conjugates
Tian, F., Lu, Y., Manibusan, A., Sellers, A., Tran, H., Sun, Y., Phuong, T., Barnett, R., Hehli, B., Song, F., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1321237111 · Cited by 319
Isodityrosine, a new cross-linking amino acid from plant cell-wall glycoprotein
Fry, S. C. (1982) · Biochemical Journal · doi:10.1042/bj2040449 · Cited by 311
Al-Obeidi, F., Castrucci, A. M. D. L., Hadley, M. E., & Hruby, V. J. (1989) · Journal of Medicinal Chemistry · doi:10.1021/jm00132a010 · Cited by 305
Glycopeptide antibiotics: Back to the future
Butler, M. S., Hansford, K. A., Blaskovich, M. A. T., Halai, R., & Cooper, M. A. (2014) · The Journal of Antibiotics · doi:10.1038/ja.2014.111 · Cited by 303
Self-citationCooper, T. W. J., Campbell, I. B., & Macdonald, S. J. F. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.201002238 · Cited by 299
Presentation and Detection of Azide Functionality in Bacterial Cell Surface Proteins
Link, A. J., Vink, M. K. S., & Tirrell, D. A. (2004) · Journal of the American Chemical Society · doi:10.1021/ja047629c · Cited by 297
Amiram, M., Haimovich, A. D., Fan, C., Wang, Y.-S., Aerni, H.-R., Ntai, I., Moonan, D. W., Ma, N. J., Rovner, A. J., Hong, S. H., et al. (2015) · Nature Biotechnology · doi:10.1038/nbt.3372 · Cited by 282
Kwong, A. D., Kauffman, R. S., Hurter, P., & Mueller, P. (2011) · Nature Biotechnology · doi:10.1038/nbt.2020 · Cited by 274
Addie, M., Ballard, P., Buttar, D., Crafter, C., Currie, G., Davies, B. R., Debreczeni, J., Dry, H., Dudley, P., Greenwood, R., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm301762v · Cited by 230
Blackwell, H. E., Sadowsky, J. D., Howard, R. J., Sampson, J. N., Chao, J. A., Steinmetz, W. E., O'Leary, D. J., & Grubbs, R. H. (2001) · The Journal of Organic Chemistry · doi:10.1021/jo015533k · Cited by 222
Highly active cyclic and bicyclic somatostatin analogues of reduced ring size
VEBER, D. F., HOLLY, F. W., NUTT, R. F., BERGSTRAND, S. J., BRADY, S. F., HISRSCHMANN, R., GLITZER, M. S., & SAPERSTEIN, R. (1979) · Nature · doi:10.1038/280512a0 · Cited by 213
Discovery and Development of Simeprevir (TMC435), a HCV NS3/4A Protease Inhibitor
Rosenquist, Å., Samuelsson, B., Johansson, P.-O., Cummings, M. D., Lenz, O., Raboisson, P., Simmen, K., Vendeville, S., de Kock, H., Nilsson, M., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401507s · Cited by 213
Discovery of MK-5172, a Macrocyclic Hepatitis C Virus NS3/4a Protease Inhibitor
Harper, S., McCauley, J. A., Rudd, M. T., Ferrara, M., DiFilippo, M., Crescenzi, B., Koch, U., Petrocchi, A., Holloway, M. K., Butcher, J. W., et al. (2012) · ACS Medicinal Chemistry Letters · doi:10.1021/ml300017p · Cited by 201
Optimized clinical performance of growth hormone with an expanded genetic code
Cho, H., Daniel, T., Buechler, Y. J., Litzinger, D. C., Maio, Z., Putnam, A.-M. H., Kraynov, V. S., Sim, B.-C., Bussell, S., Javahishvili, T., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100387108 · Cited by 199
Cobicistat (GS-9350): A Potent and Selective Inhibitor of Human CYP3A as a Novel Pharmacoenhancer
Xu, L., Liu, H., Murray, B. P., Callebaut, C., Lee, M. S., Hong, A., Strickley, R. G., Tsai, L. K., Stray, K. M., Wang, Y., et al. (2010) · ACS Medicinal Chemistry Letters · doi:10.1021/ml1000257 · Cited by 195
An intramolecular linkage involving isodityrosine in extensin
Epstein, L., & Lamport, D. T. A. (1984) · Phytochemistry · doi:10.1016/s0031-9422(00)80433-1 · Cited by 183
Approaches toward Selective Inhibition of Nitric Oxide Synthase
Marletta, M. A. (1994) · Journal of Medicinal Chemistry · doi:10.1021/jm00039a001 · Cited by 183
Discovery of Vaniprevir (MK-7009), a Macrocyclic Hepatitis C Virus NS3/4a Protease Inhibitor
McCauley, J. A., McIntyre, C. J., Rudd, M. T., Nguyen, K. T., Romano, J. J., Butcher, J. W., Gilbert, K. F., Bush, K. J., Holloway, M. K., Swestock, J., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm9015526 · Cited by 178
Peptide-based inhibitors of protein–protein interactions
Wójcik, P., & Berlicki, Ł. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.12.084 · Cited by 178
From epoxomicin to carfilzomib: chemistry, biology, and medical outcomes
Kim, K. B., & Crews, C. M. (2013) · Natural Product Reports · doi:10.1039/c3np20126k · Cited by 175
Immunotoxins and Anticancer Drug Conjugate Assemblies: The Role of the Linkage between Components
Dosio, F., Brusa, P., & Cattel, L. (2011) · Toxins · doi:10.3390/toxins3070848 · Cited by 166
Liu, Q., Yang, Q., Sun, W., Vogel, P., Heydorn, W. E., Yu, X.-Q., Hu, Z., Yu, W., Jonas, B., Pineda, R., et al. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.132670 · Cited by 165
Condon, S. M., Mitsuuchi, Y., Deng, Y., LaPorte, M. G., Rippin, S. R., Haimowitz, T., Alexander, M. D., Kumar, P. T., Hendi, M. S., Lee, Y.-H., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500176w · Cited by 164
Werner, H. M., Cabalteja, C. C., & Horne, W. S. (2016) · ChemBioChem · doi:10.1002/cbic.201500312 · Cited by 160
Theonellamide F. A novel antifungal bicyclic peptide from a marine sponge Theonella sp
Matsunaga, S., Fusetani, N., HASHIMOTO, K., & Walchli, M. R. (1989) · Journal of the American Chemical Society · doi:10.1021/ja00189a035 · Cited by 158
Suicide substrates for the alanine racemase of Escherichia coli B
Wang, E., & Walsh, C. T. (1978) · Biochemistry · doi:10.1021/bi00600a028 · Cited by 156
Jiang, Y., Andrews, S. W., Condroski, K. R., Buckman, B. O., Serebryany, V., Wenglowsky, S., Kennedy, A. L., Madduru, M. R., Wang, B., Lyon, M. A., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400164c · Cited by 152
Raja, A., LaBonte, J. A., Lebbos, J., & Kirkpatrick, P. N. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1258 · Cited by 151
Matrix Metalloproteinase Inhibitors: A Structure−Activity Study
Levy, D. E., Lapierre, F., Liang, W., Ye, W., Lange, C. W., Li, X., Grobelny, D. W., Casabonne, M., Tyrrell, D. J., Holme, K. R., et al. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm970494j · Cited by 147
Modulating Oxytocin Activity and Plasma Stability by Disulfide Bond Engineering
Muttenthaler, M., Andersson, Å., de Araujo, A. D., Dekan, Z., Lewis, R. J., & Alewood, P. F. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100989w · Cited by 140
Lorenz, M., Evers, A., & Wagner, M. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.05.022 · Cited by 135
NESTOR, J. J. J., Ho, T. L., Simpson, R. A., Horner, B. L., Jones, G. H., McRae, G. I., & VICKERY, B. H. (1982) · Journal of Medicinal Chemistry · doi:10.1021/jm00349a006 · Cited by 127
Andersson, E., Hedman‐Lagerlöf, E., Enander, J., Djurfeldt, D. R., Ljótsson, B., Červenka, S., Isung, J., Svanborg, C., Mataix‐Cols, D., Kaldo, V., et al. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.0546 · Cited by 124
Stevenazzi, A., Marchini, M., Sandrone, G., Vergani, B., & Lattanzio, M. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.10.016 · Cited by 119
Encinas, L., O’Keefe, H. P., Neu, M., Remuiñán, M. J., Patel, A., Guardia, A. C., Davie, C. P., Pérez-Macías, N., Yang, H., Convery, M. A., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401326j · Cited by 119
Scola, P. M., Sun, L., Wang, A. X., Chen, J., Sin, N., Venables, B. L., Sit, S., Chen, Y., Cocuzza, A. J., Bilder, D. M., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500297k · Cited by 116
Pizzonero, M., Dupont, S., Babel, M., Beaumont, S., Bienvenu, N., Blanqué, R., Cherel, L., Christophe, T., Crescenzi, B., Lemos, E. D., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm5012885 · Cited by 113
Hunt, S. (1985) · Springer eBooks · doi:10.1007/978-94-009-4832-7_4 · Cited by 105
Drug Discovery and Protein Tyrosine Phosphatases
Blaskovich, M. A. T. (2009) · Current Medicinal Chemistry · doi:10.2174/092986709788612693 · Cited by 104
Self-citationPerucca, E., Yasothan, U., Clincke, G., et al. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2764 · Cited by 104
Phenylalanine and Phenylglycine Analogues as Arginine Mimetics in Dengue Protease Inhibitors
Weigel, L. F., Nitsche, C., Graf, D., Bartenschlager, R. F. W., & Klein, C. D. P. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00612 · Cited by 103
Ornstein, P. L., Bleisch, T. J., Arnold, M. B., Kennedy, J. H., Wright, R. A., Johnson, B. G., Tizzano, J. P., Helton, D. R., Kallman, M. J., Schoepp, D. D., et al. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm970498o · Cited by 100
Inhibition of Growth of Hair by Mimosine
Crounse, R. G., Maxwell, J. D., & Blank, H. (1962) · Nature · doi:10.1038/194694b0 · Cited by 98
Geistlinger, T. R., & Guy, R. K. (2003) · Journal of the American Chemical Society · doi:10.1021/ja0348391 · Cited by 94
Llinàs‐Brunet, M., Bailey, M. D., Goudreau, N., Bhardwaj, P. K., Bordeleau, J., Bös, M., Bousquet, Y., Cordingley, M. G., Duan, J., Forgione, P., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100690x · Cited by 93
Farmer, L. J., Ledeboer, M. W., Hoock, T. C., Arnost, M. J., Bethiel, R. S., Bennani, Y. L., Black, J., Brummel, C. L., Chakilam, A. R., Dorsch, W. A., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00301 · Cited by 91
Seigal, B. A., Connors, W. H., Fraley, A. W., Borzilleri, R. M., Carter, P. H., Emanuel, S. L., Fargnoli, J., Kim, K., Lei, M., Naglich, J. G., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/jm501892g · Cited by 86
Kindler, H. L., Burris, H. A., Sandler, A. B., & Oliff, I. A. (2009) · Investigational New Drugs · doi:10.1007/s10637-008-9160-1 · Cited by 79
Unnatural amino acid mutagenesis-based enzyme engineering
Ravikumar, Y., Nadarajan, S. P., Yoo, T. H., Lee, C., & Yun, H. (2015) · Trends in biotechnology · doi:10.1016/j.tibtech.2015.05.002 · Cited by 79
Novel Furin Inhibitors with Potent Anti‐infectious Activity
Hardes, K., Becker, G. L., Lu, Y., et al. (2015) · ChemMedChem · doi:10.1002/cmdc.201500103 · Cited by 78
Ornstein, P. L., Bleisch, T. J., Arnold, M. B., Wright, R. A., Johnson, B. G., & Schoepp, D. D. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm970497w · Cited by 76
Scola, P. M., Wang, A. X., Good, A. C., Sun, L., Combrink, K. D., Campbell, J. A., Chen, J., Tu, Y., Sin, N., Venables, B. L., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401840s · Cited by 76
Sato, T., Izawa, K., Aceña, J. L., Liu, H., & Soloshonok, V. A. (2016) · European Journal of Organic Chemistry · doi:10.1002/ejoc.201600112 · Cited by 76
Fouché, M., Schaefer, M., Berghausen, J., Desrayaud, S., Blatter, M., Piéchon, P., Dix, I., Garcia, A. M., & ROTH, H. ‐. (2016) · ChemMedChem · doi:10.1002/cmdc.201600082 · Cited by 75
Recent advances in bioorthogonal reactions for site-specific protein labeling and engineering
Gong, Y., & Pan, L. (2015) · Tetrahedron Letters · doi:10.1016/j.tetlet.2015.03.065 · Cited by 73
Monn, J. A., Prieto, L., Taboada, L., Pedregal, C., Hao, J., Reinhard, M. R., Henry, S. S., Goldsmith, P. J., Beadle, C. D., Walton, L., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/jm501612y · Cited by 71
Soth, M., Hermann, J. C., Yee, C., Alam, M., Barnett, J. W., Berry, P. W., Browner, M. F., Frank, K. B., Frauchiger, S., Harris, S. F., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm301646k · Cited by 67
Hamada, T., Sugawara, T., Matsunaga, S., & Fusetani, N. (1994) · Tetrahedron Letters · doi:10.1016/s0040-4039(00)75851-5 · Cited by 67
Dicarba Analogues of α-Conotoxin RgIA. Structure, Stability, and Activity at Potential Pain Targets
Chhabra, S., Belgi, A., Bartels, P., van Lierop, B. J., Robinson, S. D., Kompella, S. N., Hung, A., Callaghan, B. P., Adams, D. J., Robinson, A. J., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm501126u · Cited by 65
Chen, H., Thomas, M. G., O'Connor, S. E., Hubbard, B. K., Burkart, M. D., & Walsh, C. T. (2001) · Biochemistry · doi:10.1021/bi0115434 · Cited by 65
Mosberg, H. I., Yeomans, L., Anand, J. P., Porter, V. R., Sobczyk‐Kojiro, K., Traynor, J. R., & Jutkiewicz, E. M. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm5002088 · Cited by 56
Cathepsin C Inhibitors: Property Optimization and Identification of a Clinical Candidate
Furber, M., Tiden, A. K., Gardiner, P., Mete, A., Ford, R., Millichip, I., Stein, L., Mather, A. N., Kinchin, E. C., Luckhurst, C. A., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401705g · Cited by 56
Wallace, G. C., & Fukuto, J. M. (1991) · Journal of Medicinal Chemistry · doi:10.1021/jm00109a032 · Cited by 54
LaPlante, S. R., Nar, H., Lemke, C. T., Jakalian, A., Aubry, N., & Kawai, S. H. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm401338c · Cited by 53
Asami, T., Nishizawa, N., Matsui, H., Nishibori, K., Ishibashi, Y., Horikoshi, Y., Nakayama, M., Matsumoto, S.-I., Tarui, N., Yamaguchi, M., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm401056w · Cited by 53
Caroff, E., Hubler, F., Meyer, E. A., Renneberg, D., Gnerre, C., Treiber, A., Rey, M., Hess, P., Steiner, B., Hilpert, K., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00933 · Cited by 52
Design of Cell-Permeable Stapled Peptides as HIV-1 Integrase Inhibitors
Long, Y., Huang, S.-X., Zawahir, Z., Xu, Z.-L., Li, H., Sanchez, T. W., Zhi, Y., Houwer, S. D., Christ, F., Debyser, Z., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm4006516 · Cited by 52
Beaulieu, P. L., Bös, M., Cordingley, M. G., Chabot, C., Fazal, G., Garneau, M., Gillard, J. R., Jolicoeur, E., LaPlante, S. R., McKercher, G., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm3006788 · Cited by 52
Mechanism of inactivation of γ-cystathionase by β,β,β-trifluoroalanine
Silverman, R. B., & Abeles, R. H. (1977) · Biochemistry · doi:10.1021/bi00644a019 · Cited by 49
Solanas, C., de la Torre, B. G., Fernández‐Reyes, M., Santiveri, C. M., Jiménez, M. A., Rivas, L., Jiménez, A. I., Andreu, D., & Cativiela, C. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100143f · Cited by 43
Phillips, D. P., Gao, W., Yang, Y., Zhang, G., Lerario, I. K., Lau, T. L. S., Jiang, J., Wang, X., Nguyen, D. G., Bhat, B. G., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401731q · Cited by 43
Bork, K., Yasothan, U., & Kirkpatrick, P. N. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2694 · Cited by 43
Testa, C., Scrima, M., Grimaldi, M., D’Ursi, A. M., Dirain, M. L. S., Lubin‐Germain, N., Singh, A., Haskell‐Luevano, C., Chorev, M., Rovero, P., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm501027w · Cited by 42
Synthesis of four diastereomeric enkephalins incorporating cyclopropyl phenylalanine
Mapelli, C., Kimura, H., & Stammer, C. H. (1986) · International journal of peptide & protein research · doi:10.1111/j.1399-3011.1986.tb03265.x · Cited by 39
cis‐Peptide Bonds: A Key for Intestinal Permeability of Peptides?
Marelli, U. K., Ovadia, O., Frank, A. O., Chatterjee, J., Gilon, C., Hoffman, A., & Kessler, H. (2015) · Chemistry - A European Journal · doi:10.1002/chem.201501600 · Cited by 38
Hashimoto, K., Saito, B., Miyamoto, N., Oguro, Y., Tomita, D., Shiokawa, Z., Asano, M., Kakei, H., Taya, N., Kawasaki, M., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm301674z · Cited by 38
Schiefer, I. T., Tapadar, S., Litosh, V. A., Siklos, M. I., Scism, R. A., Wijewickrama, G. T., Chandrasena, E. P., Sinha, V., Tavassoli, E., Brunsteiner, M., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm4006719 · Cited by 38
Feelders, R. A., Yasothan, U., & Kirkpatrick, P. N. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3788 · Cited by 33
Parsy, C., Alexandre, F.-R., Bidau, V., Bonnaterre, F., Brandt, G., Caillet, C., Cappelle, S., Chaves, D., Convard, T., Derock, M., et al. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.09.009 · Cited by 27
Schwyzer, R., Kim, Q., Eberlé, A. N., & Fauchère, J. (1981) · Helvetica Chimica Acta · doi:10.1002/hlca.19810640712 · Cited by 27
The discovery and development of boceprevir
Rotella, D. P. (2013) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2013.843525 · Cited by 27
Heard, K. R., Wu, W., Li, Y., Zhao, P., Woźnica, I., Lai, J. H.-S., Beinborn, M., Sanford, D. G., DiMare, M. T., Chiluwal, A. K., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400423p · Cited by 26
Gazdik, M., Jarman, K. E., O’Neill, M. T., Hodder, A. N., Lowes, K. N., Sabroux, H. J., Cowman, A. F., Boddey, J. A., & Sleebs, B. E. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.03.027 · Cited by 23
Monn, J. A., Valli, M. J., Massey, S. M., Hao, J., Reinhard, M. R., Bures, M. G., Heinz, B. A., Wang, X.-S., Carter, J. H., Getman, B. G., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm4000165 · Cited by 22
A Model for Hydride Transfer in Thymidylate Synthase Based on Unnatural Amino Acid Mutagenesis
Barrett, J. E., Lucero, C. G., & Schultz, P. G. (1999) · Journal of the American Chemical Society · doi:10.1021/ja991040+ · Cited by 19
Cai, M., Marelli, U. K., Bao, J., Beck, J. G., Opperer, F., Rechenmacher, F., McLeod, K. R., Zingsheim, M. R., Doedens, L., Kessler, H., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00102 · Cited by 19
Discovery of spirocyclic proline tryptophan hydroxylase-1 inhibitors
Goldberg, D. R., Lombaert, S. D., Aiello, R. J., Bourassa, P., Barucci, N., Zhang, Q., Paralkar, V. M., Valentine, J. J., & Zavadoski, W. J. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2016.01.064 · Cited by 18
Stereoselective Synthesis of β‐(5‐Arylthiazolyl) α‐Amino Acids and Use in Neurotensin Analogues
Hapău, D., Rémond, E., Fanelli, R., Vivancos, M., René, A., Côté, J., Besserer‐Offroy, É., Longpré, J., Martínez, J., Zaharia, V., et al. (2016) · European Journal of Organic Chemistry · doi:10.1002/ejoc.201501495 · Cited by 16
Lanreotide autogel in acromegaly – a decade on
Kyriakakis, N., Chau, V., Lynch, J. M., Orme, S. M., & Murray, R. D. (2014) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2014.970173 · Cited by 14
Kozikowski, A., Steensma, D. H., Varasi, M., Pshenichkin, S., Surina, E., & Wroblewski, J. (1998) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(98)00052-3 · Cited by 10
Synthesis, antiviral activity and resistance of a novel small molecule HIV-1 entry inhibitor
Curreli, F., Haque, K., Xie, L., Qiu, Q., Xu, J., Yong, W., Tong, X., & Debnath, A. K. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.11.006 · Cited by 10
Intermolecular Peptide Cross‐Linking by Using Diaminodicarboxylic Acids
Kamalov, M., Kaur, H., & Brimble, M. A. (2016) · Chemistry - A European Journal · doi:10.1002/chem.201503458 · Cited by 10
Fletcher, G. A., & Young, G. T. (1972) · Journal of the Chemical Society Perkin Transactions 1 · doi:10.1039/p19720001867 · Cited by 9
Discovery of diamide compounds as diacylglycerol acyltransferase 1 (DGAT1) inhibitors
Nakajima, K., April, M., Brewer, J. T., Daniels, T., Forster, C. J., Gilmore, T. A., Jain, M., Kanter, A. D., Kwak, Y., Li, J., et al. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2016.01.025 · Cited by 7
Cited by
Quest for Novel Chemical Entities through Incorporation of Silicon in Drug Scaffolds
Ramesh, R., & Reddy, D. S. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00718 · Cited by 624
Fluorine‐Containing Drugs Approved by the FDA in 2018
Mei, H., Han, J., Fustero, S., Medio‐Simon, M., Sedgwick, D. M., Santi, C., Ruzziconi, R., & Soloshonok, V. A. (2019) · Chemistry – A European Journal · doi:10.1002/chem.201901840 · Cited by 454
Photocatalysis in the Life Science Industry
Candish, L., Collins, K. D., Cook, G. C., Douglas, J. J., Gómez-Suárez, A., Jolit, A., & Keess, S. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00416 · Cited by 428
Considerations and Caveats in Combating ESKAPE Pathogens against Nosocomial Infections
Ma, Y., Wang, C., Li, Y., Li, J., Wan, Q., Chen, J., Tay, F. R., & Niu, L. (2020) · Advanced Science · doi:10.1002/advs.201901872 · Cited by 314
The self-disproportionation of enantiomers (SDE) of amino acids and their derivatives
Han, J., Wzorek, A., Kwiatkowska, M., Soloshonok, V. A., & Klika, K. D. (2019) · Amino Acids · doi:10.1007/s00726-019-02729-y · Cited by 52
Metadata
- Authors
- Blaskovich, M. A. T.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2016-09-30
- Volume
- 59
- Issue
- 24
- Pages
- 10807-10836
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W2516283850
- Cited by
- 635
- References
- 123
- FWCI
- 13.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.